Latest IT Recruitment Jobs

MSAT Molecule Steward

This role involves providing end-to-end technical leadership for a pharmaceutical product throughout its lifecycle, from development to commercial manufacturing. The Molecule Steward ensures robust product control strategies, drives continuous process improvement, and coordinates technical strategy across drug substance, drug product, and analytical teams. The position requires deep scientific expertise, regulatory knowledge, and leadership in a matrixed global environment to maintain product quality and manufacturability.

GSK East Hertfordshire, United Kingdom €103,500 – €172,500 pa

Hybrid Permanent

Senior Director, Portfolio Integration Lead - Hematology

This role leads scientific and strategic integration across GSK’s hematology oncology portfolio, ensuring alignment and innovation in clinical development. The Senior Director acts as a cross-asset thought leader, shaping disease-level strategies, biomarker approaches, and trial designs while collaborating with senior teams and external experts. It emphasizes portfolio coherence, data-driven decision-making, and clinical trial innovation within a matrix environment.

GSK Stevenage, United Kingdom US$242,250 – US$403,750 pa

Hybrid Permanent

Senior Director Clinical Operations Asset Lead - Hepatology, renal and cardiovascular disease

This role leads clinical operations for high-complexity assets in hepatology, renal, and cardiovascular disease, with a focus on global Phase III outcomes trials, rare disease programmes, and co-development partnerships. The position drives end-to-end operational strategy, including country and site selection, patient recruitment, risk management, and vendor oversight, while ensuring alignment with clinical development and evidence generation plans. It also involves direct leadership of clinical teams, fostering innovation in trial design, and maintaining inspection readiness across the portfolio.

GSK US$242,550 – US$404,250 pa

On-site Permanent

Senior Director Clinical Operations Asset Lead - Hepatology, renal and cardiovascular disease

This role leads clinical operations for high-impact, complex global trials in hepatology, renal, and cardiovascular disease, with a focus on late-phase outcomes studies and rare diseases. The position involves shaping operational strategy, managing CRO partnerships, and driving innovation in trial design while ensuring quality and compliance. Leadership includes direct management of clinical teams and strategic input into asset development across the R&D pipeline.

GSK US$242,550 – US$404,250 pa

On-site Permanent

Senior Director Clinical Operations Asset Lead - Hepatology, renal and cardiovascular disease

This role leads clinical operations for complex, high-impact assets in hepatology, renal, and cardiovascular disease, with responsibility for global Phase III trials, rare disease programmes, and co-development partnerships. The position involves setting operational strategy, managing CROs and vendors, driving data-led decision-making, and ensuring trial delivery to time, cost, and quality. It also includes direct leadership of clinical operations teams and integration of innovative trial methodologies.

GSK US$242,550 – US$404,250 pa

On-site Permanent

Senior Director Clinical Operations Asset Lead - Hepatology, renal and cardiovascular disease

This role leads clinical operations for high-complexity assets in hepatology, renal, and cardiovascular disease, with a focus on global Phase III outcomes trials, rare disease programmes, and co-development partnerships. The position drives operational strategy, risk management, and innovation in trial design, while managing senior vendor relationships and developing clinical teams. It emphasizes data-led decision-making, enterprise-wide impact, and compliance across a global development portfolio.

GSK US$242,550 – US$404,250 pa

On-site Permanent

Executive Medical Director, Clinical Development Lead - Oncology - Lung & Head/Neck Cancers

This role leads clinical strategy for oncology assets focused on lung and head/neck cancers, shaping end-to-end development plans and scientific narratives across the asset lifecycle. The Executive Medical Director acts as the principal clinical authority, aligning cross-functional teams on strategic decision-making, benefit-risk frameworks, and regulatory positioning. They leverage advanced analytics and AI-driven insights to accelerate data-informed decisions while representing Clinical Development in governance, external engagements, and talent development.

GSK Switzerland US$242,250 – US$403,750 pa

Hybrid Permanent

Executive Medical Director, Clinical Development Lead - Oncology - Lung & Head/Neck Cancers

This role leads the clinical strategy for oncology assets focused on lung and head/neck cancers, defining the scientific narrative, benefit-risk framework, and development roadmap across the asset lifecycle. The Executive Medical Director acts as the clinical authority, shaping strategic decisions, governance, and external engagement while leveraging AI and advanced analytics to accelerate development. They lead talent development and ensure alignment across clinical, regulatory, and commercial functions to deliver impactful cancer therapies.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Executive Medical Director, Clinical Development Lead - Oncology - Lung & Head/Neck Cancers

This role leads the clinical strategy and scientific narrative for oncology assets focused on lung and head/neck cancers, shaping end-to-end development from discovery to approval. The Executive Medical Director acts as the strategic leader within cross-functional teams, driving integrated decision-making, regulatory engagement, and evidence generation using advanced analytics and AI. They are responsible for mentoring talent, influencing enterprise-level governance, and ensuring clinical development aligns with patient needs and commercial readiness.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Executive Medical Director, Clinical Development Lead - Oncology - Lung & Head/Neck Cancers

This role leads clinical strategy for oncology assets focused on lung and head/neck cancers, defining the scientific narrative and benefit-risk framework across the development lifecycle. The Executive Medical Director serves as the primary clinical authority, shaping strategic decisions, guiding regulatory engagement, and integrating insights from data and technology to accelerate impactful therapies. They will mentor clinical talent and drive innovation in development models within a global biopharma environment.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Executive Medical Director, Clinical Development Lead - Oncology - Lung & Head/Neck Cancers

This role leads clinical strategy and scientific vision for oncology assets focused on lung and head/neck cancers, shaping end-to-end development from discovery to approval. The Executive Medical Director drives integrated decision-making across regulatory, commercial, and clinical domains, leveraging advanced analytics and AI to accelerate impactful therapies. They serve as a key governance leader and external representative, ensuring strategic alignment across functions and stakeholders.

GSK

Hybrid Permanent

Director, Oncology Clinical Biomarkers

This role involves developing and implementing biomarker strategies for late-stage oncology clinical trials, collaborating with cross-functional teams to identify patient populations and optimize drug development. The Director will leverage cutting-edge technologies and methodologies to validate biomarkers and inform clinical decisions.

GSK Stevenage, United Kingdom £189,750 – £316,250 pa

On-site Permanent

Director, Oncology Clinical Biomarkers

This role involves developing and implementing biomarker strategies to support the clinical development of late-stage oncology assets. Responsibilities include collaborating with cross-functional teams, validating biomarker strategies, and integrating them into clinical plans to optimize decision-making and patient stratification.

GSK United States £189,750 – £316,250 pa

On-site Permanent

Director, Oncology Clinical Biomarkers

This role involves developing and implementing biomarker strategies to support the clinical development of late-stage oncology assets. Responsibilities include collaborating with cross-functional teams, validating biomarker strategies, and integrating them into clinical plans to optimize decision-making and patient stratification.

GSK £189,750 – £316,250 pa

On-site Permanent

Director, Oncology Clinical Biomarkers

This role involves developing and implementing biomarker strategies to support the clinical development of late-stage oncology assets. Responsibilities include collaborating with cross-functional teams, validating biomarker strategies, and integrating these into clinical plans to optimize decision-making and patient stratification.

GSK £189,750 – £316,250 pa

On-site Permanent